Oct 2026· Biochemical Genetics· Vol 64, pp. 8639 - 8658· 0 citations· 38 references
Medicine
TL;DR
GAS5 suppresses HCC by modulating the miR-18a-5p-CADM2 axis and suggests that GAS5 and its downstream network may serve as potential therapeutic targets.
Purpose This study aims to screen key miRNA/mRNA axes associated with hepatocellular carcinoma (HCC), and then conduct functional validation and mechanistic exploration, thereby offering novel clues for screening HCC-targeted therapeutic candidates. Methods Bioinformatics analysis was performed to identify key HCC-rela...
Ai-Hui Fan, Xiao-Min Zhang, Hong-Jing Cui et al.· Journal of Hepatocellular Ca...· 0 citations
Epithelial ovarian cancer (EOC) is a highly lethal malignant tumor, with a poor clinical prognosis due to its early peritoneal metastasis. However, the molecular mechanism driving this malignant spread has not been elucidated. In this study, by aggregating the post-transcriptional regulatory network mediated by long no...
Wen-Xiao Li, Xiao-Li Ma, Zhi-Hui Li et al.· Discover Oncology· 0 citations
Evidence is provided for a novel UCA1 interaction regulatory network in bladder cancer, that is, UCA1-miR-582-5p-ATG7-autophagy axis, which provides a new insight into the treatment of bladder cancer.
Jun-Feng Wu, Wei Li, Jin-Zhuo Ning et al.· 0 citations
It is demonstrated that the lncRNA AP003469.2/miR-4732-3p/LIPT1 axis could suppress cuproptosis to promote HCC progression and may serve as a target for HCC treatment or diagnosis.
Jin-Long Huo, Shu-Man Kuang, Lin Wu et al.· Frontiers in Oncology· 0 citations
The long noncoding RNA AFAP1-AS1 is aberrantly expressed in multiple solid tumors, but its functional role in hepatocellular carcinoma (HCC) remains incompletely characterized. In this study, analysis of the TCGA-LIHC cohort and eight paired HCC and matched adjacent non-tumor tissues showed that AFAP1-AS1 was upregul...
It is suggested that lnc-DNAJC3-AS1 promotes GC progression, at least in part, through the miR-576-5p/LYPLA1 pathway, providing a potential target for GC treatment.
Zhen-Ni Sun, Ya-Sai Yao, Zhi-Jian Xu et al.· American Journal of Cancer R...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.